The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R&D spending are expected to drive the growth of this market during the forecast period. However, the high cost of resins is expected to limit the growth of this market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962

Protein A Resin is an affinity chromatography medium designed for easy, one-step purification of classes, subclasses, and fragments of immunoglobulin are from biological fluids and from cell culture media

Protein A Resin Market

Market Segmentation

Based on type, the protein A resin market is segmented into recombinant protein A and natural protein A. In 2020, the recombinant protein A segment is expected to is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the frequent use of recombinant protein A resins during the production of monoclonal antibodies.

Based on application, the protein A resin market is segmented into antibody purification and immunoprecipitation. In 2020, the antibody purification segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the increasing demand for monoclonal antibodies for therapeutic as well as research purposes, which has driven the demand for protein A resins used in the downstream processing of these antibodies.

Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users. the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the protein A resin market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.

Regional Analysis

North America is expected to account for the largest share of the global protein A resin market. The large share of North America is attributed to the A strong monoclonal antibody therapeutics market in North America is the key driver for the protein A resin market in the region.

Key Market Players:

The prominent players in the global protein A resin market include GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan).

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962

The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period.

GE Healthactre (US) is one of the the leading players in the global protein A resin market. The company has a vast sales network in North America, Asia, and Europe. Its strong sales network, along with strategies such as new product launches, investments, and agreements, are driving the company’s growth in the protein A resin market.